Clinical Trials Directory

Trials / Unknown

UnknownNCT03010410

Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aging is associated with immunosenescence and impaired host defense mechanisms, contributing to influenza-related morbidity and mortality. Preliminary data demonstrate that the platelet transcriptome is markedly different between healthy subjects and influenza patients. Interferon-induced transmembrane proteins (IFITM) family members are among the transcripts significantly increased in platelets during influenza and expression of IFITM-3 is impaired in elderly subjects, a pattern associated with increased mortality. This study will build on these data and investigate if aging influences the expression of platelet IFITM family members in patients with influenza and sepsis. This study will prospectively determine if aging alters the induction of (IFITMs) in platelets from hospitalized influenza and sepsis patients. The study will also determine if diminished expression of IFITM family members correlates with an increased risk of adverse outcomes in older influenza and sepsis patients.

Detailed description

This will be a prospective observational cohort study comparing older (age≥65) and younger (age\<65) influenza and sepsis patients.

Conditions

Timeline

Start date
2014-12-21
Primary completion
2019-10-01
Completion
2019-12-01
First posted
2017-01-05
Last updated
2019-08-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03010410. Inclusion in this directory is not an endorsement.